株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

自己免疫疾患診断の世界市場:競合情勢、予測、市場機会

Global Autoimmune Disease Diagnostics Market By Type, By Sex, By Age, By Factors, By Diagnosis, By Types of Treatment, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 934738
出版日 ページ情報 英文 113 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=109.72円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

自己免疫疾患診断の世界市場:競合情勢、予測、市場機会 Global Autoimmune Disease Diagnostics Market By Type, By Sex, By Age, By Factors, By Diagnosis, By Types of Treatment, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025
出版日: 2020年05月01日 ページ情報: 英文 113 Pages
概要

世界の自己免疫疾患診断市場は2019年に40億米ドルと評価され、2025年までは堅牢なCAGRで成長すると予測されます。自己免疫疾患診断市場の成長を牽引する主な要因は、 医療セクターへの投資の急増です。さらに、増加する自己免疫疾患の症例は、今後数年間で世界中の自己免疫疾患診断市場の成長の前兆となることが予想されます。さらに、資金提供に関する政府の支援の増加は、2025年までの市場成長を後押しすると予測され、米国や欧州などの発展途上国でのラボ自動化技術の実装の増加は、市場の成長をさらに助けています。

当レポートは、世界の自己免疫疾患診断市場を、タイプ別、性別、年齢別、要因別、診断別、治療タイプ別、製品別、エンドユーザー別、地域別で調査したもので、市場規模や市場シェアの予測、促進要因と課題、競合情勢、主要企業プロファイルなどの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の自己免疫疾患診断市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別(全身、臓器固有(ローカライズ))
    • 性別(男性、女性)
    • 年齢別(0-15、15-44、44 +)
    • 要因別(食事、遺伝学、環境要因)
    • 診断別(抗核抗体検査(ANR)、自己抗体検査、CBC(全血球数)、包括的代謝パネル、C反応性タンパク質(CRP)、赤血球沈降速度(ESR)、尿検査、画像検査、生検)
    • 治療タイプ別(非ステロイド性抗炎症薬(NSAID)、免疫抑制薬、ホルモン補充療法、理学療法、輸血、血漿交換、その他)
    • 製品別(キットとアッセイ、試薬、機器)
    • エンドユーザー別(病院、診療所、診断検査室、その他)
    • 企業別(2019年)
    • 地域別
  • 市場の魅力指数

第5章 アジア太平洋の自己免疫疾患診断市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 性別
    • 年齢別
    • 要因別
    • 診断別
    • 治療タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場の魅力指数
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • シンガポール
    • オーストラリア

第6章 欧州の自己免疫疾患診断市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 性別
    • 年齢別
    • 要因別
    • 診断別
    • 治療タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場の魅力指数
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第7章 北米の自己免疫疾患診断市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 性別
    • 年齢別
    • 要因別
    • 診断別
    • 治療タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場の魅力指数
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 南米の自己免疫疾患診断市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 性別
    • 年齢別
    • 要因別
    • 診断別
    • 治療タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場の魅力指数
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第9章 中東・アフリカの自己免疫疾患診断市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • タイプ別
    • 性別
    • 年齢別
    • 要因別
    • 診断別
    • 治療タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場の魅力指数
  • 中東・アフリカ地域:国別分析
    • 南アフリカ
    • サウジアラビア
    • UAE

第10章 市場力学

  • 促進要因
  • 課題

第11章 市場動向と発展

第12章 競合情勢

  • 競合の展望
  • 主要企業プロファイル
    • Siemens
    • Abbott
    • Bio-Rad Laboratories
    • Pfizer
    • Johnson and Johnson
    • Grifols
    • Trinity Biotech
    • Thermo Fisher Scientific
    • Inova Diagnostics
    • Hycor Biomedical
    • Euroimmun
    • Protagen
    • Roche
    • Quest Diagnostics
    • Hemagen Diagnostics
    • Aesku Diagnostics
    • Sanofi
    • Sun Pharmaceutical Industries Ltd.
    • Eli Lilly
    • Bayer

第13章 戦略的推奨事項

第14章 会社と免責事項について

目次
Product Code: 4544

Global autoimmune disease diagnostics market size was valued at USD4 billion in 2019 and projected to grow at a formidable CAGR during the forecast period. The key factor driving the growth of autoimmune disease diagnostics market is surging investment in healthcare sector. Additionally, growing cases of autoimmune diseases is further anticipated to bode well for the growth of autoimmune disease diagnostics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025. Moreover, growing implementation of lab automation technologies in developing nations such as U.S. and Europe are further aiding the market growth.

The global autoimmune disease diagnostics market is segmented based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, region and company. Based on product, the market can be segmented into kits and assays, reagents and instruments. Out of which, the kits and assays segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to increasing adoption of kits and assays in hospitals and clinical laboratories. Moreover, increasing prevalence of autoimmune diseases coupled with growing requirement for fast results, is expected to boost the growth of the segment in the upcoming years.

Major players operating in the autoimmune disease diagnostics market include Siemens, Abbott, Bio-Rad Laboratories, Pfizer, Johnson and Johnson, Grifols, Trinity Biotech, Thermo Fisher Scientific, Inova Diagnostics, Hycor Biomedical, Euroimmun, Protagen, Roche, Quest Diagnostics, Hemagen Diagnostics, Aesku Diagnostics, Sanofi, Sun Pharmaceutical Industries Ltd., Eli Lilly, Bayer, etc. The companies operating in autoimmune disease diagnostics market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as mergers and acquisitions, among others in order to survive the highly competitive industry.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global autoimmune disease diagnostics market.
  • To classify and forecast global autoimmune disease diagnostics market based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global autoimmune disease diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoimmune disease diagnostics market.
  • To conduct pricing analysis for global autoimmune disease diagnostics market.
  • To identify and analyse the profile of leading players operating in global autoimmune disease diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global autoimmune disease diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Autoimmune disease diagnostics companies and other stakeholders.
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to autoimmune disease diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global autoimmune disease diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Systemic

Organ-specific

  • Market, By Sex:

Male

Female

  • Market, By Age:

0-15

15-44

44+

  • Market, By Factors:

Diet

Genetics

Environmental Agents

  • Market, By Diagnosis:

Antinuclear Antibody Test

Autoantibody Test

CBC

Comprehensive Metabolic Panel

C-reactive Protein

Erythrocyte Sedimentation Rate

Urinalysis

Imaging Test

Biopsy

  • Market, By Types of Treatment:

Nonsteroidal Anti-Inflammatory Drugs

Immune-Suppressing Drugs

Hormone Replacement Therapy

Physical Therapy

Blood Transfusion

Plasma Exchange

Others

  • Market, By Product:

Kits and Assays

Reagents

Instruments

  • Market, By End-User:

Hospital

Clinics

Diagnostic Laboratories

Others

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global autoimmune disease diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Autoimmune Disease Diagnostics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type (Systemic, Organ-specific (Localized))
    • 4.2.2. By Sex (Male, Female)
    • 4.2.3. By Age (0-15, 15-44, 44+)
    • 4.2.4. By Factors (Diet, Genetics, Environmental agents)
    • 4.2.5. By Diagnosis (Antinuclear antibody test (ANR), Autoantibody test, CBC (Complete Blood Count), Comprehensive Metabolic Panel, C-reactive protein (CRP), Erythrocyte sedimentation rate (ESR), Urinalysis, Imaging test, Biopsy)
    • 4.2.6. By Types of Treatment (Nonsteroidal anti-inflammatory drugs (NSAIDs), Immune-suppressing drugs, Hormone replacement therapy, Physical therapy, Blood transfusion, Plasma Exchange, Others)
    • 4.2.7. By Product (Kits and assays, Reagents, Instruments)
    • 4.2.8. By End-User (Hospital, Clinics, Diagnostic laboratories, Others)
    • 4.2.9. By Company (2019)
    • 4.2.10. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Autoimmune Disease Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Sex
    • 5.2.3. By Age
    • 5.2.4. By Factors
    • 5.2.5. By Diagnosis
    • 5.2.6. By Types of Treatment
    • 5.2.7. By Product
    • 5.2.8. By End-User
    • 5.2.9. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Autoimmune Disease Diagnostics Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Type
        • 5.4.1.2.2. By Sex
        • 5.4.1.2.3. By Age
        • 5.4.1.2.4. By Factors
        • 5.4.1.2.5. By Diagnosis
        • 5.4.1.2.6. By Types of Treatment
        • 5.4.1.2.7. By Product
        • 5.4.1.2.8. By End-User
    • 5.4.2. India Autoimmune Disease Diagnostics Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Type
        • 5.4.2.2.2. By Sex
        • 5.4.2.2.3. By Age
        • 5.4.2.2.4. By Factors
        • 5.4.2.2.5. By Diagnosis
        • 5.4.2.2.6. By Types of Treatment
        • 5.4.2.2.7. By Product
        • 5.4.2.2.8. By End-User
    • 5.4.3. Japan Autoimmune Disease Diagnostics Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Type
        • 5.4.3.2.2. By Sex
        • 5.4.3.2.3. By Age
        • 5.4.3.2.4. By Factors
        • 5.4.3.2.5. By Diagnosis
        • 5.4.3.2.6. By Types of Treatment
        • 5.4.3.2.7. By Product
        • 5.4.3.2.8. By End-User
    • 5.4.4. South Korea Autoimmune Disease Diagnostics Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Type
        • 5.4.4.2.2. By Sex
        • 5.4.4.2.3. By Age
        • 5.4.4.2.4. By Factors
        • 5.4.4.2.5. By Diagnosis
        • 5.4.4.2.6. By Types of Treatment
        • 5.4.4.2.7. By Product
        • 5.4.4.2.8. By End-User
    • 5.4.5. Singapore Autoimmune Disease Diagnostics Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Type
        • 5.4.5.2.2. By Sex
        • 5.4.5.2.3. By Age
        • 5.4.5.2.4. By Factors
        • 5.4.5.2.5. By Diagnosis
        • 5.4.5.2.6. By Types of Treatment
        • 5.4.5.2.7. By Product
        • 5.4.5.2.8. By End-User
    • 5.4.6. Australia Autoimmune Disease Diagnostics Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Type
        • 5.4.6.2.2. By Sex
        • 5.4.6.2.3. By Age
        • 5.4.6.2.4. By Factors
        • 5.4.6.2.5. By Diagnosis
        • 5.4.6.2.6. By Types of Treatment
        • 5.4.6.2.7. By Product
        • 5.4.6.2.8. By End-User

6. Europe Autoimmune Disease Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Sex
    • 6.2.3. By Age
    • 6.2.4. By Factors
    • 6.2.5. By Diagnosis
    • 6.2.6. By Types of Treatment
    • 6.2.7. By Product
    • 6.2.8. By End-User
    • 6.2.9. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Autoimmune Disease Diagnostics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Type
        • 6.4.1.2.2. By Sex
        • 6.4.1.2.3. By Age
        • 6.4.1.2.4. By Factors
        • 6.4.1.2.5. By Diagnosis
        • 6.4.1.2.6. By Types of Treatment
        • 6.4.1.2.7. By Product
        • 6.4.1.2.8. By End-User
    • 6.4.2. Germany Autoimmune Disease Diagnostics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Type
        • 6.4.2.2.2. By Sex
        • 6.4.2.2.3. By Age
        • 6.4.2.2.4. By Factors
        • 6.4.2.2.5. By Diagnosis
        • 6.4.2.2.6. By Types of Treatment
        • 6.4.2.2.7. By Product
        • 6.4.2.2.8. By End-User
    • 6.4.3. United Kingdom Autoimmune Disease Diagnostics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Type
        • 6.4.3.2.2. By Sex
        • 6.4.3.2.3. By Age
        • 6.4.3.2.4. By Factors
        • 6.4.3.2.5. By Diagnosis
        • 6.4.3.2.6. By Types of Treatment
        • 6.4.3.2.7. By Product
        • 6.4.3.2.8. By End-User
    • 6.4.4. Italy Autoimmune Disease Diagnostics Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Type
        • 6.4.4.2.2. By Sex
        • 6.4.4.2.3. By Age
        • 6.4.4.2.4. By Factors
        • 6.4.4.2.5. By Diagnosis
        • 6.4.4.2.6. By Types of Treatment
        • 6.4.4.2.7. By Product
        • 6.4.4.2.8. By End-User
    • 6.4.5. Spain Autoimmune Disease Diagnostics Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Type
        • 6.4.5.2.2. By Sex
        • 6.4.5.2.3. By Age
        • 6.4.5.2.4. By Factors
        • 6.4.5.2.5. By Diagnosis
        • 6.4.5.2.6. By Types of Treatment
        • 6.4.5.2.7. By Product
        • 6.4.5.2.8. By End-User
        • 6.4.5.2.9.

7. North America Autoimmune Disease Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Sex
    • 7.2.3. By Age
    • 7.2.4. By Factors
    • 7.2.5. By Diagnosis
    • 7.2.6. By Types of Treatment
    • 7.2.7. By Product
    • 7.2.8. By End-User
    • 7.2.9. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Autoimmune Disease Diagnostics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Sex
        • 7.4.1.2.3. By Age
        • 7.4.1.2.4. By Factors
        • 7.4.1.2.5. By Diagnosis
        • 7.4.1.2.6. By Types of Treatment
        • 7.4.1.2.7. By Product
        • 7.4.1.2.8. By End-User
    • 7.4.2. Mexico Autoimmune Disease Diagnostics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Sex
        • 7.4.2.2.3. By Age
        • 7.4.2.2.4. By Factors
        • 7.4.2.2.5. By Diagnosis
        • 7.4.2.2.6. By Types of Treatment
        • 7.4.2.2.7. By Product
        • 7.4.2.2.8. By End-User
    • 7.4.3. Canada Autoimmune Disease Diagnostics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Sex
        • 7.4.3.2.3. By Age
        • 7.4.3.2.4. By Factors
        • 7.4.3.2.5. By Diagnosis
        • 7.4.3.2.6. By Types of Treatment
        • 7.4.3.2.7. By Product
        • 7.4.3.2.8. By End-User

8. South America Autoimmune Disease Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Sex
    • 8.2.3. By Age
    • 8.2.4. By Factors
    • 8.2.5. By Diagnosis
    • 8.2.6. By Types of Treatment
    • 8.2.7. By Product
    • 8.2.8. By End-User
    • 8.2.9. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Autoimmune Disease Diagnostics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Sex
        • 8.4.1.2.3. By Age
        • 8.4.1.2.4. By Factors
        • 8.4.1.2.5. By Diagnosis
        • 8.4.1.2.6. By Types of Treatment
        • 8.4.1.2.7. By Product
        • 8.4.1.2.8. By End-User
    • 8.4.2. Argentina Autoimmune Disease Diagnostics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Sex
        • 8.4.2.2.3. By Age
        • 8.4.2.2.4. By Factors
        • 8.4.2.2.5. By Diagnosis
        • 8.4.2.2.6. By Types of Treatment
        • 8.4.2.2.7. By Product
        • 8.4.2.2.8. By End-User
    • 8.4.3. Colombia Autoimmune Disease Diagnostics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Sex
        • 8.4.3.2.3. By Age
        • 8.4.3.2.4. By Factors
        • 8.4.3.2.5. By Diagnosis
        • 8.4.3.2.6. By Types of Treatment
        • 8.4.3.2.7. By Product
        • 8.4.3.2.8. By End-User

9. Middle East and Africa Autoimmune Disease Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Sex
    • 9.2.3. By Age
    • 9.2.4. By Factors
    • 9.2.5. By Diagnosis
    • 9.2.6. By Types of Treatment
    • 9.2.7. By Product
    • 9.2.8. By End-User
    • 9.2.9. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Autoimmune Disease Diagnostics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Sex
        • 9.4.1.2.3. By Age
        • 9.4.1.2.4. By Factors
        • 9.4.1.2.5. By Diagnosis
        • 9.4.1.2.6. By Types of Treatment
        • 9.4.1.2.7. By Product
        • 9.4.1.2.8. By End-User
    • 9.4.2. Saudi Arabia Autoimmune Disease Diagnostics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Sex
        • 9.4.2.2.3. By Age
        • 9.4.2.2.4. By Factors
        • 9.4.2.2.5. By Diagnosis
        • 9.4.2.2.6. By Types of Treatment
        • 9.4.2.2.7. By Product
        • 9.4.2.2.8. By End-User
    • 9.4.3. UAE Autoimmune Disease Diagnostics Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Sex
        • 9.4.3.2.3. By Age
        • 9.4.3.2.4. By Factors
        • 9.4.3.2.5. By Diagnosis
        • 9.4.3.2.6. By Types of Treatment
        • 9.4.3.2.7. By Product
        • 9.4.3.2.8. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. Siemens
    • 12.2.2. Abbott
    • 12.2.3. Bio-Rad Laboratories
    • 12.2.4. Pfizer
    • 12.2.5. Johnson and Johnson
    • 12.2.6. Grifols
    • 12.2.7. Trinity Biotech
    • 12.2.8. Thermo Fisher Scientific
    • 12.2.9. Inova Diagnostics
    • 12.2.10. Hycor Biomedical
    • 12.2.11. Euroimmun
    • 12.2.12. Protagen
    • 12.2.13. Roche
    • 12.2.14. Quest Diagnostics
    • 12.2.15. Hemagen Diagnostics
    • 12.2.16. Aesku Diagnostics
    • 12.2.17. Sanofi
    • 12.2.18. Sun Pharmaceutical Industries Ltd.
    • 12.2.19. Eli Lilly
    • 12.2.20. Bayer

13. Strategic Recommendations

14. About Us & Disclaimer